You are here

  • Home
  • Archive
  • Volume 13, Issue 3
  • Contralateral effect of systemic absorption of low dose bevacizumab (Avastin) after unilateral intravitreal injection in severe retinopathy of prematurity (ROP)

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Case report
Contralateral effect of systemic absorption of low dose bevacizumab (Avastin) after unilateral intravitreal injection in severe retinopathy of prematurity (ROP)

Authors

  1. Correspondence to Ayad Shafiq; ayad.shafiq{at}nhs.net
View Full Text

Citation

Shafiq A, Hillier R, Hearn R
Contralateral effect of systemic absorption of low dose bevacizumab (Avastin) after unilateral intravitreal injection in severe retinopathy of prematurity (ROP)
BMJ Case Reports CP 2020;13:e232359.

Publication history

  • Accepted February 26, 2020
  • First published March 12, 2020.
Online issue publication 
August 21, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.